biomedicina slovenica


pr=Čerček : 55-154

  1. Chyu KY; Dimayuga P; Zhu J; Shah PK; Nilsson J; Čerček B
    Decreased intimal thickening after injury in inducible nitric oxide synthase knock-out mice
    1999
  2. Dimayuga P; Zhu J; Oguchi S; Chyu KY; Yano J; Shah PK; Nilsson J; Čerček B
    Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff induced carotid injury in apoE null mice
    1999
  3. Lovdahl C; Thyberg J; Čerček B; Blomgren K; Dimayuga P; Kallin B; Haltgardh-Nilsson A
    Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation and migration of arterial smooth muscle cells in vitro and neointimal thickening after balloon injury in vivo
    1999
  4. Rajavashisht T; Xu XP; Meisel RS; Xu H; Fishbein MC; Kaul S; Čerček B; Sharifi B; Shah PK
    Membrane- type matrix metalloproteinase-1 is expressed in human atherosclerotic plaques: evidence for activation by proinflammatory mediators
    1999
  5. Yamashita M; Dimayuga P; Kaul S; Shah PK; Regnstrom J; Nilsson J; Čerček B
    Phosphatase activity in the arterial wall following balloon injury: effect of somatostatin analog octreotide
    1999
  6. Xu XP; Meisel RS; Ong JM; Kaul S; Čerček B; Rajavashisth TB; Sharifi B; Shah PK
    Oxidized low density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
    1999
  7. Naqvi TZ; Shah PK; Ivey PA; Molloy MD; Linn P; Linker-Israeli M; Čerček B; Kaul S
    Therapeutic concentrations of heparin potentiate platelet activation at the time of coronary angiography
    1998
  8. Dhar S; Hayes S; Čerček B; Fishbein MC
    Cardiac tuberculosis (Images in cardiovascular medicine)
    1998
  9. Calara F; Dimayuga P; Niemann A; Thyberg J; Diczfalusy U; Witztum JL; Palinski W; Shah PK; Čerček B; Nilsson J; Regnstrom J
    An animal model to study local oxidation of LDL and its biological effects in the arterial wall
    1998
  10. Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Čerček B
    Effects of recombinant apolipoprotein A-1 Milano on aortic atherosclerosis in apolipoprotein E-deficient mice
    1998
  11. Nilsson J; Dahlgren B; Ares M; Westman J; Čerček B; Shah PK
    Lipoprotein-like phospholipid particles inhibit the smooth muscle cell toxicity of lysophosphotidylcholine and platelet-activating factor
    1998
  12. Nilsson J; Calara R; Regnstrom JR; Hultgardh-Nilsson A; Ameli S; Čerček B; Shah PK
    Immunization with homologous oxidized low density lipoprotein reduces neointima formation following balloon-injury in hypercholesterolemic rabbits
    1997
  13. Nilsson J; Calara R; Regnstrom JR; Hultgardh-Nilsson A; Ameli S; Čerček B; Shah PK
    Local delivery of an ultra-short-acting oxide-releasing compound, DMHD/NO, is highly effective in inhibiting acute platelet-thrombus formation on injured arterial strips
    1997
  14. Nishioka T; Luo H; Fishbein MC; Čerček B; Forrester JS; Kim C-J; Berglund H; Siegel RJ
    Dissolution of thrombotic arterial occlusion by high intensity low frequency ultrasound and dodecafluoropentane emulsion - in vitro and in vivo study
    1997
  15. Čerček B; Yamashita M; Dimayuga P; Zhu J; Fishbein MC; Kaul S; Shah PK; Nilsson J; Renstrom J
    Nuclear factor-kappaB activity and arterial response to balloon injury
    1997
  16. Yumi K; Fagin JA; Fishbein MC; Shah PK; Kaul S; Forrester JS; Nilsson J; Čerček B
    Inhibitory effect of somatostatin analog octreotide on vascular insulin-like growth factor-I gene expression and neointimal proliferation following arterial balloon injury in rats
    1997
  17. Ameli S; Hultgardh-Nilsoon A; Regnstrom J; Calara F; Čerček B; Shah PK; Nilsson J
    Effect of immunization with homologous unmodified and oxidized low density lipoprotein on early atherosclerosis in hypercholesterolemic rabbits
    1996
  18. Luo H; Nishioka T; Fishbein MC; Čerček B; Forrester JS; Kim CJ; Berglund H; Siegel RJ
    Transcutaneous ultrasound augments lysis of arterial thrombi in vivo
    1996
  19. Luo H; Nishioka T; Berglund H; Kim CJ; Carbone M; Čerček B; Siegel RJ
    The effect of external ultrasound frequency on thrombus disruption in vitro
    1996
  20. Calara F; Ameli S; Hultgardh-Nilsson A; Čerček B; Kupfer J; Forrester JS; Shah PK; Nilsson J
    Autocrine induction of DNA synthesis by mechanical injury of smooth muscle cell culture
    1996
  21. Hultgardh-Nilsson A; Čerček B; Wang JW; Naito S; Lovdahl C; Sharifi B; Forrester JS; Fagin JA
    Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro
    1996
  22. Stiko A; Regnstrom J; Shah PK; Čerček B; Nilsson J
    Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis
    1996
  23. Nishioka T; Friedman A; Čerček B; Chaux A; Luo H; Berglund H; Kim C-J; Carlos B; Siegel RJ
    Usefulness of transesophageal echocardiography for positioning the intraaortic balloon pump in the operating room
    1996
  24. Dubin D; Peters JH; Brown LF; Logan B; Kent KC; Berse B; Berven S; Čerček B; Sharifi BG; Tratt RE
    Balloon catheterization induces arterial expression of embryonic fibronectins
    1995
  25. Zahger D; Karagounis LA; Čerček B; Anderson JL; Sorensen S; Moreno F; Shah PK
    Incomplete recanalization as an important determinant of thrombolysis in myocardial infarction (TIMI) Grade 2 flow after thrombolytic therapy for acute myocardial infarction
    1995
  26. Zahger D; Čerček B; Cannon CP; Jordan M; Shah PK
    Reduced efficacy of thrombolytic therapy for acute myocardial infarction in patients with prior coronary bypass surgery: results from the thrombolysis in myocardial infarction (TIMI) 4 trial
    1995
  27. Zahger D; Fishbein MC; Grafinkel LI; Shah PK; Forrester JS; Regnstrom J; Yano J; Čerček B
    VCL, an antagonist of the platelet PG1b receptor, markedly inhibits adhesion and intimal thickening following balloon injury in the rat
    1995
  28. Zahger D; Čerček B; Cannon CP; Davis V; Jordan M; Braunwald E; Shah PK
    How do smokers differ from non-smokers in their response to thrombolysis? Clinical, scintigraphic and angiographic observations from the thrombolysis in myocardial infarction (TIMI) 4 trial
    1994
  29. Ameli S; Hultgardh-Nilsson A; Čerček B; Shah PK; Forrester JS; Ageland H; Nilsson J
    Recombinant apolipoprotein A-I Milano reduces intimal thickening following balloon-injury in hypercholesterolemic rabbits
    1994
  30. Pirola CJ; Wang HM; Strgacich MI; Kamyar A; Čerček B; Forrester JS; Clemens TL; Fagin JA
    Mechanical stimuli induced vascular parathyroid hormone-related protein gene expression in vivo and in vitro
    1994
  31. Luo H; Steffeb W; Čerček B; Arunasalam A; Maurer G; Siegel RJ
    Enhancement of thrombolysis by external ultrasouns
    1993
  32. Shah PK; Čerček B; Lew AS; Ganz W
    Angiographic validation of beside markers of reperfusion
    1993
  33. Čerček Bojan; Shah Prediman K; Noč Marko; Zahger Doron; Zeymer Uwe; Matetzky Shiomi; Maurer Gerald; Mahrer Pete
    Effect of short-term treatment with azythromycin on recurrent ischaemic events in patients with acute coronary syndrome in the azithromycin in acute coronary syndrome (AZACS) trial: a randomised controlled trial
    2003
  34. Matetzky Shlomo; Domingo Michelle; Kar Saibal; Noč Marko; Shah Prediman K; Kaul Sanjay; Daar Eric; Čerček Bojan
    Acute myocardial infarction in human immunodeficincy virus-infected patients
    2003
  35. Noč Marko; Matetzky Shlomo; Domingo Michelle; Kar Saibal; Makkar Raj; Čerček Bojan; Litvack Frank
    Frequency of incomplete reperfusion in patients with acute myocardial infarction undergoing primary angioplasty
    2002
  36. Čerček Bojan
    HDL like particles in atherosclerosis
    2002
  37. Matetzky Shlomi; Sharir Tali; Noč Marko; Domingo Michelle; Chyu Kuang-Yuh; Kar Saibal; Eigler Nael; Kaul Sanjay; shah Prediman K; Čerček Bojan
    Primary angioplasty for acute myocardial infarction in octogenarians
    2001
  38. Accetto Rok; Pirc-Čerček Olga
    Treatment of malignant hypertension with angiotensin II receptor blockers
    2002
  39. Čerček Miha
    Lysosomal proteases, cathepsins B and L, as prognostic markers in breast carcinoma
    [Lizosomalna encima, katepsina B in L, kot prognostična pokazatelja karcinoma dojke]
    1997
  40. Čerček Miha
    Sprememba vazomotorne funkcije koronarnih in perifernih arterij pri bolnikih s koronarno aterosklerozo
    2000
  41. Cibic B; Žemva A; Pirc-Čerček O; Kolšek B
    Naše izkušnje pri zdravljenju blage in srednje težke hipertenzije z indapamidom (Arifonom)
    1983
  42. Lavrač N; Mozetič I; Zrimec T; Bratko I; Čerček B; Grad A; Horvat M; Rode P
    Ekspertni sistem za diagnosticiranje motenj srčnega ritma
    1983
  43. Solina F; Čerček B; Horvat M
    Računalniška prepoznava motenj srčnega ritma
    1983
  44. Čerček B; Horvat M; Bručan A; Grad A; Rode P
    Študij motenj ritma srca pri zdravljenju akutnega miokardnega infarkta s sistemsko infuzijo streptokinaze
    1983
  45. Bratko I; Čerček B; Horvat M; Klemenc M; Lavrač N; Mozetič I; Ribarič S
    Razvoj ekspertnega sistema za diagnosticiranje, prognostiko in zdravljenje motenj srčnega ritma
    1984
  46. Grad A; Kranjec I; Čerček B; Horvat M
    Študij aktivnosti serumskih encimov, funkcije levega prekata po kratkotrajni visokodozirani infuziji streptokinaze pri bolnikih z akutnim miokardnim infarktom
    1984
  47. Čerček B; Horvat M; Bručan A; Grad A; Rode P
    Študij motenj srčnega ritma pri zdravljenju akutnega miokardnega infarkta s sistemsko infuzijo streptokinaze
    1984
  48. Čerček B; Horvat M; Gaspari L; Milčinski M
    Fibrinolitično zdravljenje akutnega miokardnega infarkta
    1984
  49. Dobovišek J; Lapanja Z; Pirc-Čerček O; Jezeršek P
    Hipertenzija kot dejavnik tveganja za koronarno srčno bolezen
    1984
  50. Rode P; Horvat M; Koželj T; Geršak B; Bručan A; Čerček B
    Naše prve izkušnje v uporabi aortne črpalke pri zdravljenju težjega popuščanja srca
    1984
  51. Čerček B; Horvat M; Grad A; Bručan A; Rode P
    Fibrinolitično zdravljenje akutnega miokardnega infarkta
    1984
  52. Rakovec P; Čerček B; Rode P; Bručan A; Horvat M
    Sotalolinduced torsade de pointes
    1984
  53. Horvat M; Rakovec P; Cijan A; Bručan A; Rode P; Čerček B; Milčinski M; Grad A; Jakopin J; Markež J; Bljelogrlić Z; Kolšek B; Žemva A; Obrez I; Jager F; Janežič A; Bardorfer I; Zorman D; Ramovš A; Rutar V; Starc R; Kenda M; Turk J; Medvešček M; Mrevlje F; Zupančič-Brovet I
    Motnje srčnega ritma
    1982
  54. Čerček B
    Študij motenj ritma srca pri zdravljenju akutnega miokardnega infarkta s sistemsko infuzijo streptokinaze
    1984
  55. Koželj T; Rode P; Horvat M; Geršak B; Bručan A; Čerček B
    Teoretični vidiki uporabe intraaortne balonske črpalke
    1983
  56. Lavrač N; Mozetič I; Zrimec T; Bratko I; Čerček B; Grad A; Horvat M; Rode P
    Ekspertni sistem za diagnosticiranje motenj srčnega ritma
    1983
  57. Čerček B; Horvat M; Bručan A; Grad A; Rode P; Milčinski-Veselko M
    Kratkotrajna, visokodozirana intravenska infuzija streptokinaze v času prvih treh ur akutnega miokardnega infarkta
    1983
  58. Zrimec T; Čerček B; Rode P; Lavrač N; Mozetič I; Bratko I; Kononenko I; Grad A
    An expert consultation system for cardiac arrhythmias
    1983
  59. Čerček B; Horvat M
    Načela ambulantnega zdravljenja odpovedi srca
    1982
  60. Čerček B; Grad A; Horvat M
    VPLIV STAROSTI NA OžIVLJANJE BOLNIKOV NA ODDELKU INTENZIVNE TERAPIJE
    1982
  61. Grad A; Horvat M; Milčinski M; Bručan A; Rode P; Čerček B
    PREGLED ZDRAVLJENJA BOLNIKOV PRED RECIDIVOM MIOKARDNEGA INFARKTA
    1980
  62. Rode P; Čerček B; Bručan A; Horvat M
    HIPERTENZIVNA KRIZA
    1978
  63. Pirc-Čerček O; Žemva A
    ZDRAVLJENJE HIPERTENZIVNE SRčNE BOLEZNI
    1978
  64. Pirc-Čerček O
    LABORATORIJSKE PREISKAVE NA DRUGI STOPNJI DIAGNOSTIKE ARTERIJSKE HIPERTENZIJE
    1978
  65. Čerček Miha
    Sprememba vazomotorne funkcije koronarnih in perifernih arterij pri bolnikih s koronarno aterosklerozo
    [Change in coronary and peripheral vascular function in patients with coronary atherosclerosis]
    2001
  66. Matetzky Shlomo; Sharir Tali; Domingo Michelle; Noč Marko; Chyu Kuang-Yuh; Kaul Sanjay; Eigler Neal; Shah Prediman K; Čerček Bojan
    Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction
    2000
  67. Marn-Pernat A; Accetto R; Pirc-Čerček O
    Malignant hypertension - report of four cases
    2000
  68. Marn-Pernat Andreja; Accetto Rok; Pirc-Čerček Olga
    Malignant hypertension - report of four cases
    2000
  69. Lah Tamara T; Čerček Miha; Blejec Andrej; Kos Janko; Gorodetsky Ella; Somers Robert; Daskal Ierachmiel
    Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    2000
  70. Čerček B
    The role of tropomoms in management of acute corornary syndromes
    1998
  71. Čerček B
    Indications for coronary artery bypass operation in patients with acute myocardial infarction
    1998
  72. Čerček B
    Inflammation and coronary artery disease
    1998
  73. Čerček B
    The role of troponins in management of acute coronary syndromes
    1998
  74. Emelianov Dmitri; Accetto R; Bučič B; Dobovišek J; Dolenc P; Kolšek B; Lapanja Z; Mihelič-Bričič M; Petrin J; Perc-Čerček O; Žemva A
    Conventional and ambulatory measurements of blood pressure in old patients with isolated systolic hypertension: baseline observtions in the Syst-Eur trial
    1998
  75. Pirc-Čerček Olga
    Nujna stanja v poteku arterijske hipertenzije: maligna arterijska hipertenzija
    1997
  76. Pirc-Čerček Olga
    Klinično merjenje krvnega tlaka
    1997
  77. Pirc-Čerček Olga
    Definicija in merjenje krvnega tlaka: definicija hipertenzije
    1997
  78. Čerček B
    Reperfusion in patients with cardiogenic shock
    1994
  79. Levičar N; Čerček M; Blejec A; Golouh R; Frković-Grazio S; Vrhovec I; Brunner N; Kos J; Lah T
    Relative prognostic significance of cysteine proteinases, urokinase and their inhibitors in breast cancer patients
    1997
  80. Čerček Miha; Kalman Endre; Kos Janko; Blejec Andrej; Tanney Don; Daskal Ierachmiel; Lah Tamara
    Lysosomal proteinases, cathepsins D, B and L in human breast carcinoma: relative prognostic significance
    1997
  81. Levičar N; Čerček M; Blejec A; Golouh R; Grazio Ž; Vrhovec I; Brunner N; Kos J; Lah T
    Relative prognostic significance of cysteine proteinases, urokinase and their inhibitors in breast cancer patients
    1997
  82. Levičar N; Čerček M; Blejec A; Golouh R; Gracio Ž; Vrhovec I; Brunner N; Kos J; Lah T
    Clinical relevance of cysteine and serine proteinases in breast cancer
    1997
  83. Lah TT; Čerček M; Kos J; Lowder J; Gorodetsky E; Daskal I
    Epidermal growth factor receptor (EGFR), Her-2
    1996
  84. Pirc-Čerček O; Bucić B
    Arterijska hipertenzija in koronarna bolezen
    1991
  85. Čerček B
    Prehospital treatment of acute myocardial infarction
    1994
  86. Pirc-Čerček O; Lapanja Z
    Posebnosti zdravljenja hipertenzije v starosti
    1994
  87. Jezeršek P; Accetto R; Cibic B; Dobovišek J; Kolšek B; Lapanja Z; Mihelič-Brčič M; Petrin J; Pirc-Čerček O; Zaletel-Kragelj L; Žemva A
    Assessment of levels of hypertension control and management in SR Slovenia: a part of the WHO hypertension control program
    1987
  88. Wilhelmsen L; Strasser T; Jezeršek P; Accetto R; Cibic B; Dobovišek J; Dolenc P; Kolšek B; Kralj Z; Lapanja Z; Mihelić-Brčić M; Petrin J; Pirc-Čerček O; Zaletel-Kragelj L; Žemva A
    WHO-WHL Hypertension Management Audit Project
    1993
  89. Čerček B
    Routine management of acute myocardial infarction - current state of knowledge
    1994
  90. Pirc-Čerček O; Dobovišek J
    Maligna arterijska hipertenzija
    1993
  91. Dobovišek J; Pirc-Čerček O; Lapanja Z
    Sekundarna arterijska hipertenzija
    1993
  92. Jezeršek P; Accetto R; Cibic B; Dobovišek J; Dolenc P; Kolšek B; Kralj Z; Lapanja Z; Mihelčič-Brčič M; Petrin J; Pirc-Čerček O; Zaletel-Kragelj L; Žemva A
    Šiška, a suburb of Ljubljana, Slovenia
    1993
  93. Pirc-Čerček O
    Maligna arterijska hipertenzija
    1992
  94. Pirc-Čerček O
    Merjenje krvnega tlaka
    1992
  95. Pirc-Čerček O; Dobovišek J
    Maligna arterijska hipertenzija
    1992
  96. Jezeršek Pavle; Accetto Rok; Cibic Boris; Dobovišek Jurij; Kolšek Borut; Lapanja Zdenko; Mihelič-Brčič Maja; Petrin Jurij; Pirc-Čerček Olga; Zaletel-Kragelj Lijana; Žemva Aleš
    Epidemiološka študija arterijske hipertenzije v SR Sloveniji
    [Epidemiological assessment of arterial hypertension in republic Slovenia]
    1988
  97. Jezeršek P; Accetto R; Cibic B; Dobovišek J; Kolšek B; Kralj Z; Lapanja Z; Mihelčič-Brčič M; Petrin J; Pirc-Čerček O; Zaletel-Kragelj L; Žemva A
    Epidemiološka študija arterijske hipertenzije v SR Sloveniji
    1987
  98. Jezeršek P; Accetto R; Cibic B; Dolenc P; Dobovišek J; Kolšek B; Lapanja Z; Mihelič-Brčič M; Petrin J; Pirc-Čerček O; Pogačnik T; Preželj J; Švab I; Žemva A
    Arterijska hipertenzija
    1987
  99. Jezeršek P; Accetto R; Cibic B; Dobovišek J; Kolšek B; Kralj Z; Lapanja Z; Mihelič-Brčič M; Petrin J; Pirc-Čerček O; Zaletel-Kragelj L; Žemva A
    Epidemiološki podatki o arterijski hipertenziji v SR Sloveniji
    1987
  100. Jezeršek P; Accetto R; Cibic B; Dobovišek J; Kolšek B; Lapanja Z; Mihelič-Brčič M; Petrin J; Pirc-Čerček O; Preželj J; Švab I; Žemva A
    Arterijska hipertenzija
    1986

   1 55


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics